Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy

J Clin Med. 2023 Jun 9;12(12):3937. doi: 10.3390/jcm12123937.

Abstract

Dilated cardiomyopathy (DCM) has a genetic cause in up to 40% of cases, with differences in disease penetrance and clinical presentation, due to different exogeneous triggers and implicated genes. Cardiac inflammation can be the consequence of an exogeneous trigger, subsequently unveiling a phenotype. The study aimed to determine cardiac inflammation in a cohort of genetic DCM patients and investigate whether it associated with a younger disease onset. The study included 113 DCM patients with a genetic etiology, of which 17 had cardiac inflammation as diagnosed in an endomyocardial biopsy. They had a significant increased cardiac infiltration of white blood, cytotoxic T, and T-helper cells (p < 0.05). Disease expression was at a younger age in those patients with cardiac inflammation, compared to those without inflammation (p = 0.015; 50 years (interquartile range (IQR) 42-53) versus 53 years (IQR 46-61). However, cardiac inflammation was not associated with a higher incidence of all-cause mortality, heart failure hospitalization, or life-threatening arrhythmias (hazard ratio 0.85 [0.35-2.07], p = 0.74). Cardiac inflammation is associated with an earlier disease onset in patients with genetic DCM. This might indicate that myocarditis is an exogeneous trigger unveiling a phenotype at a younger age in patients with a genetic susceptibility, or that cardiac inflammation resembles a 'hot-phase' of early-onset disease.

Keywords: diagnosis; dilated cardiomyopathy; genetics; inflammation; myocarditis.

Grants and funding

We acknowledge the support of the Netherlands Cardiovascular Research Initiative, an initiative with the support of the Dutch Heart Foundation, CVON Arena-PRIM (2017-18), and the DCVA DOUBLE DOSIS (2020). J.A.J.V. is supported by a research grant from the Dutch Heart Foundation.